News & Press Releases
Filter by:
Mintz Advises Seven Starling on $8M Series A-Prime Financing
September 19, 2025
Mintz advised Seven Starling, a virtual health provider specializing in mental health care during fertility, pregnancy, postpartum, and early parenthood, on its $8M Series A-Prime financing, led by Rethink Impact.
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz advised Charlesbank Capital Partners, a middle-market private investment firm, on its acquisition of Q6 Cyber, an intelligence and fraud prevention services provider.
State AGs May Level Antitrust Enforcement Against ESG and AI
September 15, 2025
Peter Saparoff, Chair of Mintz’s Institutional Investor Class Action Recovery Practice, and Associate Sofia Nuño published an article in Bloomberg Law examining how state attorneys general are increasingly applying antitrust and consumer-protection laws to asset managers’ ESG and AI stewardship practices, marking a shift toward more aggressive state-level enforcement beyond federal oversight.
Mintz Advises the Placement Agents in CAMP4’s up to $100 Million Private Placement
September 12, 2025
Mintz advised the placement agents in connection with CAMP4's up to $100 million private placement. The private placement included upfront gross proceeds of $50 million in exchange for common stock (and pre-funded warrants in lieu of common stock for certain investors). In addition, CAMP4 will be eligible to receive up to an additional $50 million in gross proceeds in exchange for common stock (and pre-funded warrants for certain investors), subject to achieving pre-specified milestones, including receipt of regulatory clearance to initiate a Phase 1/2 clinical trial in SYNGAP patients with its development candidate, CMP-SYNGAP-01.
Mintz Advises Premier Wealth Advisor Breed’s Hill Capital on Acquisition by Corient
September 12, 2025
Mintz represented Breed’s Hill Capital, a multi-family office overseeing approximately $3.5 billion in assets, in its acquisition by Corient, one of the nation’s leading wealth management firms. The transaction enhances Corient’s footprint in New England and advances its ability to deliver personalized fiduciary wealth management services across the region.